reconstitution bpc 157 BPC-157 and Dosing How to Reconstitute BPC 157:

TB-500 protocol considerations Reported dosing in the research literature: Starting dose: 500 mcg daily, subcutaneous injection Titration: Increase by 100 to 150 mcg every two weeks as tolerated Target dose: 750 to 1000 mcg daily by weeks five through twelve Weekly total: Approximately 5 mg per week at full dose Cycle length: Eight to twelve weeks, with optional extension to sixteen weeks TB-500 is typically administered once daily via subcutaneous injection, with consistent timing and systematic site rotation

Modulates nitric oxide (NO) signaling It influences nitric oxide synthase activity, affecting vascular tone and tissue perfusion, which is essential for delivering oxygen and nutrients to healing tissues

Single-use syringes must never be reused

Molecular Composition : Molecular formula CHNO, molar mass 1,419.5 g/mol, ensuring precise chemical consistency